Macrolide-Resistant <i>Mycoplasma pneumoniae</i> Infections among Children before and during COVID-19 Pandemic, Taiwan, 2017–2023
Tsung-Hua Wu, Yu-Ping Fang, Fang‐Ching Liu, Hui-Hsien Pan, Yuying Yang, Chiah-Sing Song, Chun‐Yi Lee
Abstract
Before the COVID-19 pandemic, Mycoplasma pneumoniae infections emerged during spring to summer yearly in Taiwan, but infections were few during the pandemic. M. pneumoniae macrolide resistance soared to 85.7% in 2020 but declined to 0% during 2022-2023. Continued molecular surveillance is necessary to monitor trends in macrolide-resistant M. pneumoniae.
Topics & Concepts
Mycoplasma pneumoniaePandemicCoronavirus disease 2019 (COVID-19)Virology2019-20 coronavirus outbreakPneumoniaSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineBiologyMicrobiologyOutbreakInfectious disease (medical specialty)Internal medicineDiseasePneumonia and Respiratory InfectionsRespiratory viral infections researchBacterial Infections and Vaccines